Finance

Lists
Why is ALMKT down 3,38%?
Dive Deeper
ALMKT:EPA
Mauna Kea Technologies SA
0,12 €
-3,38%
(-0,0042) 1D
5 հոկ, 17:35:04 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALMKT...
Open
0,13 €
High
0,13 €
Low
0,12 €
Mkt. cap
24,25 մլն
Avg. vol.
440,14 հզր
Volume
560,78 հզր
P/E ratio
0,98
52-wk high
0,23 €
52-wk low
0,07 €
EPS
0,12 €
Shares outstanding
195,26 մլն
No. of employees
59
Open
0,13 €
High
0,13 €
Low
0,12 €
Mkt. cap
24,25 մլն
Avg. vol.
440,14 հզր
Volume
560,78 հզր
P/E ratio
0,98
52-wk high
0,23 €
52-wk low
0,07 €
EPS
0,12 €
Shares outstanding
195,26 մլն
No. of employees
59
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
15 րոպե առաջ
The Nasdaq logo is displayed on a screen at the Nasdaq Market site in New York
Tahlequah Daily Press
Tahlequah Daily Press
·
13 րոպե առաջ
US stocks rise to the edge of an all-time high
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts. The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues. Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time. Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA
CEOSacha Loiseau
Employees59
Founded2000
Headquarters-
Sector-
Last report
15 հնվ, 2026 թ.
Fiscal period
Q4 2025
EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
2,44 մլն / -
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
2,02 մլն
2,02 մլն
2,44 մլն
2,44 մլն
Cost of goods sold
396,00 հզր
396,00 հզր
528,00 հզր
528,00 հզր
Cost of revenue
396,00 հզր
396,00 հզր
528,00 հզր
528,00 հզր
Research and development expenses
818,50 հզր
818,50 հզր
861,00 հզր
861,00 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,90 մլն
1,90 մլն
1,89 մլն
1,89 մլն
Operating expense
3,02 մլն
3,02 մլն
3,11 մլն
3,11 մլն
Total operating expenses
3,41 մլն
3,41 մլն
3,64 մլն
3,64 մլն
Operating income
-1,40 մլն
-1,40 մլն
-1,20 մլն
-1,20 մլն
Other non operating income
-695,00 հզր
-695,00 հզր
10,84 մլն
10,84 մլն
EBT including unusual items
-2,31 մլն
-2,31 մլն
7,69 մլն
7,69 մլն
EBT excluding unusual items
-2,20 մլն
-2,20 մլն
8,06 մլն
8,06 մլն
Income tax expense
28,00 հզր
28,00 հզր
-35,50 հզր
-35,50 հզր
Effective tax rate
-1,21%
-1,21%
-0,46%
-0,46%
Other operating expenses
83,00 հզր
83,00 հզր
92,00 հզր
92,00 հզր
Net income
-2,33 մլն
-2,33 մլն
7,72 մլն
7,72 մլն
Net profit margin
-115,83%
-115,83%
316,50%
316,50%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-6,50 հզր
-6,50 հզր
-490,50 հզր
-490,50 հզր
Net interest expenses
-6,50 հզր
-6,50 հզր
-490,50 հզր
-490,50 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,35 մլն
-1,35 մլն
-1,11 մլն
-1,11 մլն
Gain or loss from assets sale
-
-
281,00 հզր
281,00 հզր
AI content may include mistakes. Learn more
Google Apps